Pharmacogenomics Flashcards

1
Q

Pharmacogenomics definition

A

variations in several genes (genome) that influence a drug’s response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Warfarin metabolism (slide 15 no.1)

A

..

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

NHS approach

A

NHS White/Board paper

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

which genotypes are involved in alterations to warfarin metabolism?

A

CYP2C9, VKORC1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Codeine metabolism

A

Codeine to morphine by CYP2D6

to norcodeine by 3A4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are recommendations for:

  1. normal (extensive) metabolisers of codeine?
  2. poor metabolisers
  3. intermediate metabolisers
  4. ultrarapid (increased formation of morphine)
A
  1. use label recommendations
  2. avoid codeine (lack of efficacy)
  3. Use label, adjust if no response
  4. avoid codeine due to potential for toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MHRA guidance for ultrarapid metabolisers?

A

codeine is contraindicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clopidogrel metabolism

A

CYP2C19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

poor clopidogrel metaboliser risks

A

2-fold increase atherosclerosis
4-fold risk of stent thrombosis
20-40% of patients non or poor responders to clopidogrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Allele meaning for tamoxifen and dose recommendations

A
  1. 2 inactive = poor metaboliser. Increase breast cancer risk
  2. 1 active/inactive or variation = intermediate. Increased risk
  3. 2 active = UM = no recommendation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

% patients with poor tamoxifen response

A

20-30% GENOTYPE STATUS NOT CONSIDERED IN DECISION MAKING

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how much could warfarin pharmacogenomic testing save in US?

A

1.1 billion dollars

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CYP variability

A

gene deletion - no enzyme - no metabolism

gene duplication - higher enzyme levels - increased metabolism of parent drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

HLA-B*1502

A

Carbamazepine increased risk of SJS and TENS (Toxic Epidermal Necrolysis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HLA-B*5701

A

Abacavir sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Type B ADRs and role of HLA

A

HLA variants trigger a T cell response triggering a sensitivity reaction